Clinical Trial

Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This Phase 3 study is designed to evaluate the efficacy and safety of IN-B00009 injection in adults with obesity or overweight without diabetes mellitus
Trial Details
NCT Number NCT07192263
Lead Sponsor HK inno.N Corporation
Conditions Obesity & Overweight
Enrollment 300 participants
Start Date 2025-09-22
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-25